FDA Inspection 738176 — Leo Pharma A/S

Leo Pharma A/S — FEI 3002807496

The FDA completed an inspection of Leo Pharma A/S on July 15, 2011 in Ballerup. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 15, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ballerup (Denmark)

Additional Details

Sponsor, Contract Research Organization